Recomendaciones de uso de palivizumab para la prevención de la infección por virus respiratorio sincitial en prematuros de 32 1 a 35 0 semanas de gestación-Reference-Cited by-同舟云学术

Recomendaciones de uso de palivizumab para la prevención de la infección por virus respiratorio sincitial en prematuros de 32 1 a 35 0 semanas de gestación

Published:2010-08 Issue:2 Volume:73 Page:98.e1-98.e4
ISSN:1695-4033
Container-title:Anales de Pediatría
language:es
Short-container-title:Anales de Pediatría

Author:

Figueras Aloy J.,Carbonell Estrany X.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference35 articles.

1. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants;Pediatrics,1998

2. Recomendaciones para la prevención de la infección por virus respiratorio sincitial;Carbonell-Estrany;An Esp Pediatr,2000

3. Recomendaciones para la prevención de la infección por virus respiratorio sincitial: Revisión;Carbonell-Estrany;An Esp Pediatr,2002

4. Recomendaciones para la prevención de la infección por virus respiratorio sincitial

5. Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections;Meissner;Pediatrics,2003

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis;European Journal of Clinical Microbiology & Infectious Diseases;2017-04-08

2. Can we improve the targeting of respiratory syncytial virus (RSV) prophylaxis in infants born 32–35 weeks’ gestational age with more informed use of risk factors?;The Journal of Maternal-Fetal & Neonatal Medicine;2014-08-14

3. Respiratory-Related Hospitalizations following Prophylaxis in the Canadian Registry for Palivizumab (2005–2012) Compared to Other International Registries;Clinical and Developmental Immunology;2013

4. Bronquiolitis y convulsiones: no siempre por apneas;Anales de Pediatría;2012-10

5. Host and environmental factors influencing respiratory secretion of pro‐wheezing biomarkers in preterm children;Pediatric Allergy and Immunology;2012-05-03